Immunoadoptive Cell Therapy News Today

/PRNewswire/ -- The "Chimeric Antigen Receptor T (CAR-T) Cells Global Market Report 2023" report has been added to ResearchAndMarkets.coms offering. The...

The market suffered a small correction this week but the underlying trend remains bullish. We expect a short rally next week before a deeper decline.

Indian shares were little changed in early trade on Thursday despite encouraging Q4 GDP data and easing U.S. debt worries. The benchmark S&P BSE Sensex was up 57 points, or 0.

We mentioned yesterday, that the markets were under pressure. On Thursday, frontline indices fell further as 2078 stocks advanced, 1458 declined and 125 remained unchanged on the Bombay Stock Exchange (BSE), with an advance decline ratio of 1.42, indicating a positive closing of stocks in broader markets.

Based on the OI percentage, 56 stocks were on the short-covering list. These included Balkrishna Industries, Divis Laboratories, Dabur India, Nestle India, and Britannia Industries.

With several years of experience in the pharma industry, Satyanarayana Chava has catapulted Laurus among the top global R&D firms.

Adoptive Cell Therapy Market to Boost the Revenue over the Forecast Period 2027

Adoptive Cell Therapy Market to Boost the Revenue over the Forecast Period 2027